PPARγ Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot Study
Activating synthetic ligands for peroxisome proliferator-activated receptor gamma (PPARγ), such as pioglitazone, are commonly used to treat persons with diabetes mellitus with improvement of insulin resistance. Several reports have clearly demonstrated that PPARγ ligands could inhibit colorectal can...
Guardat en:
| Autors principals: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2010-01-01
|
| Col·lecció: | PPAR Research |
| Accés en línia: | http://dx.doi.org/10.1155/2010/257835 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|